| Brief Cognitive Behavioral Conjoint Therapy (bCBCT) + MIDOMAFETAMINE for stress disorders, post-traumatic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Brief cognitive task-based intervention for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| CBCT + Therapy + MIDOMAFETAMINE for stress disorders, post-traumatic | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Cognitive Processing Therapy for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| D-Cycloserine (DCS) for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Dexmedetomidine hydrochloride for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| EEG-based personalized TMS for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Full Dose Midomafetamine HCl for stress disorders, post-traumatic | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Group Therapy + MIDOMAFETAMINE for stress disorders, post-traumatic | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| HB-1 for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| High THC Cannabis for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| High-intensity inpatient MDMA-assisted psychotherapy for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Ketamine for stress disorders, post-traumatic | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Ketamine Hydrochloride for stress disorders, post-traumatic | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Ketamine-Assisted Psychotherapy (KAP) for stress disorders, post-traumatic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Manualized therapy + MIDOMAFETAMINE for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Manualized therapy + Midomafetamine HCl for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| MDMA Assisted Therapy for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| MDMA-assisted Cognitive Processing Therapy (MDMA-aCPT) + MIDOMAFETAMINE for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Mdma-at for stress disorders, post-traumatic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Methylphenidate hydrochloride for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Midomafetamine for stress disorders, post-traumatic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 18 |
|---|
| Midomafetamine HCl for stress disorders, post-traumatic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 5 |
|---|
| Midomafetamine Hydrochloride for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Nightmare Deconstruction and Reprocessing for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| NightWare for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
|---|
| NightWare smartwatch configured to detect physiological signs of sympathetic activation during sleep, such as heart-rate spikes and movement patterns. for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| NightWare Therapeutic System for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 4 |
|---|
| Prolonged Exposure + MIDOMAFETAMINE for stress disorders, post-traumatic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Prolonged exposure therapy + MIDOMAFETAMINE for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Propranolol for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Psilocybin for stress disorders, post-traumatic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
|---|
| Psilocybin + MBCT therapy for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Psychotherapy + MIDOMAFETAMINE for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| Sea-it for stress disorders, post-traumatic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| SGB - Combined Solution of Bupivacaine + Ketamine Adjuvant for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Simple cognitive task for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 3 |
|---|
| SmartSleep EEG recording headband + Ketamine for stress disorders, post-traumatic | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Structured Integrated Reframing Therapy (SIRT) for stress disorders, post-traumatic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Structured Integrated Reframing Therapy (SIRT) + Psilocybin for stress disorders, post-traumatic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Therapy + MIDOMAFETAMINE for stress disorders, post-traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
|---|
| TREATMENT ARM: Full dose for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Visuospatial Task (VST) for stress disorders, post-traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|